116 related articles for article (PubMed ID: 37229955)
21. Trend of geographical distribution of stomach cancer in Iran from 2004 to 2014.
Moradian F; Fararouei M; Karami M; Ghelichi-Ghojogh M; Gheibi Z; Nikeghbalian Z; Akbari A; Akbari ME
BMC Gastroenterol; 2022 Jan; 22(1):4. PubMed ID: 34983394
[TBL] [Abstract][Full Text] [Related]
22. Overall, gender and social inequalities in suicide mortality in Iran, 2006-2010: a time trend province-level study.
Kiadaliri AA; Saadat S; Shahnavazi H; Haghparast-Bidgoli H
BMJ Open; 2014 Aug; 4(8):e005227. PubMed ID: 25138804
[TBL] [Abstract][Full Text] [Related]
23. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
AIRTUM Working Group
Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
[TBL] [Abstract][Full Text] [Related]
24. Sex differences in cancer survival in Estonia: a population-based study.
Innos K; Padrik P; Valvere V; Aareleid T
BMC Cancer; 2015 Feb; 15():72. PubMed ID: 25886269
[TBL] [Abstract][Full Text] [Related]
25. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).
Allemani C; Weir HK; Carreira H; Harewood R; Spika D; Wang XS; Bannon F; Ahn JV; Johnson CJ; Bonaventure A; Marcos-Gragera R; Stiller C; Azevedo e Silva G; Chen WQ; Ogunbiyi OJ; Rachet B; Soeberg MJ; You H; Matsuda T; Bielska-Lasota M; Storm H; Tucker TC; Coleman MP;
Lancet; 2015 Mar; 385(9972):977-1010. PubMed ID: 25467588
[TBL] [Abstract][Full Text] [Related]
26. Overall survival and prognostic factors prostate cancer in Kurdistan Province-Iran: a population-based study (2011-2018).
Rasouli MA; Moradi G; Zareie B; Sofimajidpour H; Tozandehjani S; Zafari H; Gholami F; Shahsavari S; Hassani P; Mohammadian M
BMC Cancer; 2021 Dec; 21(1):1314. PubMed ID: 34876069
[TBL] [Abstract][Full Text] [Related]
27. Regional differences in population-based cancer survival between six prefectures in Japan: application of relative survival models with funnel plots.
Ito Y; Ioka A; Tsukuma H; Ajiki W; Sugimoto T; Rachet B; Coleman MP
Cancer Sci; 2009 Jul; 100(7):1306-11. PubMed ID: 19432897
[TBL] [Abstract][Full Text] [Related]
28. Annual Trends of Gastrointestinal Cancers Mortality in Iran During 1990-2015; NASBOD Study.
Salimzadeh H; Delavari F; Sauvaget C; Rezaee N; Delavari A; Kompani F; Rezaei N; Sheidaei A; Modirian M; Haghshenas R; Chegini M; Gohari K; Zokaiee H; Farzadfar F; Malekzadeh R
Arch Iran Med; 2018 Feb; 21(2):46-55. PubMed ID: 29664654
[TBL] [Abstract][Full Text] [Related]
29. Joint Spatio-Temporal Shared Component Model with an Application in Iran Cancer Data.
Mahaki B; Mehrabi Y; Kavousi A; Schmid VJ
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1553-1560. PubMed ID: 29936779
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Bayesian Spatial Ecological Regression Models for Investigating the Incidence of Breast Cancer in Iran, 2005- 2008.
Khoshkar AH; Koshki TJ; Mahaki B
Asian Pac J Cancer Prev; 2015; 16(14):5669-73. PubMed ID: 26320433
[TBL] [Abstract][Full Text] [Related]
31. Cancer incidence in southern Iran, 1998-2002: results of population-based cancer registry.
Masoompour SM; Yarmohammadi H; Rezaianzadeh A; Lankarani KB
Cancer Epidemiol; 2011 Oct; 35(5):e42-7. PubMed ID: 21840285
[TBL] [Abstract][Full Text] [Related]
32. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
33. Geographic distribution of the incidence of colorectal cancer in Iran: a population-based study.
Khosravi Shadmani F; Ayubi E; Khazaei S; Sani M; Mansouri Hanis S; Khazaei S; Soheylizad M; Mansori K
Epidemiol Health; 2017; 39():e2017020. PubMed ID: 28774167
[TBL] [Abstract][Full Text] [Related]
34. Population-based survival from cancers having a poor prognosis in Mumbai (Bombay), India.
Yeole BB; Kumar AV
Asian Pac J Cancer Prev; 2004; 5(2):175-82. PubMed ID: 15244521
[TBL] [Abstract][Full Text] [Related]
35. Incidence and Survival of Patients With Conjunctival Melanoma in Europe.
Virgili G; Parravano M; Gatta G; Capocaccia R; Mazzini C; Mallone S; Botta L;
JAMA Ophthalmol; 2020 Jun; 138(6):601-608. PubMed ID: 32215588
[TBL] [Abstract][Full Text] [Related]
36. Measuring socioeconomic disparities in cancer incidence in Tehran, 2008.
Rohani-Rasaf M; Moradi-Lakeh M; Ramezani R; Asadi-Lari M
Asian Pac J Cancer Prev; 2012; 13(6):2955-60. PubMed ID: 22938489
[TBL] [Abstract][Full Text] [Related]
37. Burden of breast cancer in Iran: a study of the Tehran population based cancer registry.
Mousavi SM; Mohaghegghi MA; Mousavi-Jerrahi A; Nahvijou A; Seddighi Z
Asian Pac J Cancer Prev; 2006; 7(4):571-4. PubMed ID: 17250429
[TBL] [Abstract][Full Text] [Related]
38. Bayesian adjustment for trend of colorectal cancer incidence in misclassified registering across Iranian provinces.
Shojaee S; Hajizadeh N; Najafimehr H; Busani L; Pourhoseingholi MA; Baghestani AR; Nasserinejad M; Ashtari S; Zali MR
PLoS One; 2018; 13(12):e0199273. PubMed ID: 30543626
[TBL] [Abstract][Full Text] [Related]
39. Spatial Analysis of Breast Cancer Incidence in Iran.
Mahdavifar N; Pakzad R; Ghoncheh M; Pakzad I; Moudi A; Salehiniya H
Asian Pac J Cancer Prev; 2016; 17(S3):59-64. PubMed ID: 27165209
[TBL] [Abstract][Full Text] [Related]
40. Estimates of cancer burden in Lazio.
Rashid I; Pannozzo F; Rossi S; Foschi R
Tumori; 2013; 99(3):359-65. PubMed ID: 24158065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
